Influence of cholestasis on drug elimination: pharmacokinetics
- PMID: 966151
- DOI: 10.1002/jps.2600650921
Influence of cholestasis on drug elimination: pharmacokinetics
Abstract
A two-compartment model representing the body and the GI tract, with elimination occurring in each compartment, was used to study, in theory, the influence of impaired biliary excretion on drug disposition. The results suggest that cholestasis can either increase or decrease a drug's half-life, depending upon the relative values of the two elimination rate constants, In all cases, however, impaired biliary excretion reduced the initial elimination of drug from the body and increased the half-life of the alpha-phase of drug disposition.
Similar articles
-
Pharmacokinetics of drugs subject to enterohepatic circulation.J Pharm Sci. 1979 Jun;68(6):792-4. doi: 10.1002/jps.2600680634. J Pharm Sci. 1979. PMID: 458586
-
A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.J Pharm Sci. 1982 Mar;71(3):297-302. doi: 10.1002/jps.2600710308. J Pharm Sci. 1982. PMID: 7069584
-
Drug disposition and liver disease.Drug Metab Rev. 1975;4(2):139-75. doi: 10.3109/03602537508993754. Drug Metab Rev. 1975. PMID: 770104 Review. No abstract available.
-
Derivation of Laplace transform for the general disposition deconvolution equation in drug metabolism kinetics.Exp Toxicol Pathol. 1999 Jul;51(4-5):409-11. doi: 10.1016/S0940-2993(99)80030-X. Exp Toxicol Pathol. 1999. PMID: 10445406
-
Clinical pharmacokinetics of changes in drug elimination in children.Dev Pharmacol Ther. 1985;8(5):311-28. doi: 10.1159/000457054. Dev Pharmacol Ther. 1985. PMID: 3899553 Review.
Cited by
-
Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044. Pharmaceutics. 2024. PMID: 39204389 Free PMC article.
-
Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.Eur J Clin Pharmacol. 1989;37(1):79-84. doi: 10.1007/BF00609430. Eur J Clin Pharmacol. 1989. PMID: 2591469
-
A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):493-504. doi: 10.1007/s13318-018-0535-1. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30488336
-
Effect modelling for drugs undergoing enterohepatic circulation.Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):333-8. doi: 10.1007/BF03190182. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8020531
-
Diclofenac toxicity in susceptible bird species results from a combination of reduced glomerular filtration and plasma flow with subsequent renal tubular necrosis.PeerJ. 2021 Aug 23;9:e12002. doi: 10.7717/peerj.12002. eCollection 2021. PeerJ. 2021. PMID: 34513332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources